Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

Journal Article · · Nature Communications
 [1];  [1];  [1];  [1];  [2];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [3];  [4];  [4];  [1] more »;  [1];  [1];  [1];  [1];  [4];  [3];  [5];  [5];  [5];  [6];  [6];  [6];  [6];  [7];  [7];  [7];  [1];  [4];  [1];  [1];  [5];  [4];  [4];  [2];  [1] « less
  1. Walter Reed Army Institute of Research, Silver Spring, MD (United States); Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD (United States)
  2. Univ. of Maryland, Baltimore, MD (United States). School of Medicine
  3. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD (United States); Walter Reed Army Institute of Research, Silver Spring, MD (United States)
  4. Walter Reed Army Institute of Research, Silver Spring, MD (United States)
  5. Trudeau Institute, Saranac Lake, NY (United States)
  6. Uniformed Services University, Bethesda, MD (United States)
  7. Integral Molecular, Philadelphia, PA (United States)

Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. Here we show that nurse sharks immunized with SARS-CoV-2 recombinant receptor binding domain (RBD), RBD-ferritin (RFN), or spike protein ferritin nanoparticle (SpFN) immunogens elicit a set of new antigen receptor antibody (IgNAR) molecules that target two non-overlapping conserved epitopes on the spike RBD. Representative shark antibody variable NAR-Fc chimeras (ShAbs) targeting either of the two epitopes mediate cell-effector functions, with high affinity to all SARS-CoV-2 viral variants of concern, including the divergent Omicron strains. The ShAbs potently cross-neutralize SARS-CoV-2 WA-1, Alpha, Beta, Delta, Omicron BA.1 and BA.5, and SARS-CoV-1 pseudoviruses, and confer protection against SARS-CoV-2 challenge in the K18-hACE2 transgenic mouse model. Structural definition of the RBD-ShAb01-ShAb02 complex enabled design and production of multi-specific nanobodies with enhanced neutralization capacity, and picomolar affinity to divergent sarbecovirus clade 1a, 1b and 2 RBD molecules. These shark nanobodies represent potent immunotherapeutics both for current use, and future sarbecovirus pandemic preparation.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
2423606
Journal Information:
Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 14; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (42)

Shark immunity bites back: affinity maturation and memory response in the nurse shark, Ginglymostoma cirratum journal February 2005
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development journal November 2020
Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display journal September 2003
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? journal July 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies journal May 2020
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection journal April 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity journal December 2021
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike journal September 2020
The immunoglobulins of cartilaginous fishes journal February 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy journal September 2021
Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction journal October 2021
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples journal March 2011
Maturation of Shark Single-domain (IgNAR) Antibodies: Evidence for Induced-fit Binding journal March 2007
Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries journal September 2011
A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks journal March 1995
SARS and MERS: recent insights into emerging coronaviruses journal June 2016
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography journal December 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge journal October 2021
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies journal October 2020
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants journal June 2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations journal October 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody journal February 2021
Versatile C 3 -symmetric scaffolds and their use for covalent stabilization of the foldon trimer journal January 2014
An evolutionarily mobile antigen receptor variable region gene: Doubly rearranging NAR-TcR genes in sharks journal March 2006
First molecular and biochemical analysis ofin vivoaffinity maturation in an ectothermic vertebrate journal January 2006
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice journal November 2008
SARS-like WIV1-CoV poised for human emergence journal March 2016
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants journal August 2020
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice journal April 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques journal September 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies journal January 2021
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation journal February 2020
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 journal November 2020
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape journal January 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates journal February 2022
Mechanisms of Zoonotic Severe Acute Respiratory Syndrome Coronavirus Host Range Expansion in Human Airway Epithelium journal December 2007
Applications of Nanobodies journal February 2021
COVID-19 Outbreak: An Overview journal January 2019
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein journal January 2021
A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2 journal March 2021
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies journal April 2021
Structural insights and biomedical potential of IgNAR scaffolds from sharks journal January 2015

Similar Records

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
Journal Article · Thu Oct 27 00:00:00 EDT 2022 · Immunity · OSTI ID:2006467

Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Journal Article · Tue Jan 02 23:00:00 EST 2024 · Nature Communications · OSTI ID:2470226

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
Journal Article · Sun Jul 02 20:00:00 EDT 2023 · Journal of Virology · OSTI ID:2423689